BioMarin Pharmaceutical Inc. (BMRN: News ) announced that its first quarter GAAP net loss was $13.2 million or $0.13 per share, compared to GAAP net income of $1.7 million or $0.02 per share for the first quarter of 2008.
Non-GAAP net income was $9.3 million or $0.09 per share for the first quarter of 2009, compared to non-GAAP net income of $4.1 million or $0.04 per share for the first quarter of 2008.
Total revenues for the quarter was $73.98 million, compared to $60.40 million in the prior year quarter.
Analysts polled by Thomson Reuters expected the company to report a loss of $0.12 per share on revenues of $74.04 million for the quarter. Analysts' estimates typically exclude special items.
For the fiscal 2009, total net product revenues are still expected to be in the range of $300 million to $329 million. GAAP result is still expected to be loss of $15 million - $0 million, and non-GAAP net income to be $33.7 million - $51.7 million.
Analysts expect the company to report a loss of $0.07 per share on revenues of $324.57 million for fiscal 2009.
No comments:
Post a Comment